Paper27436699
Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.
Uzun S and 9 others. Ren Fail, 2016. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3. Papers, record 27436699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27436699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| C-Reactive Protein | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Nephropathies | Major topic |
| Interleukin-1 | Major topic |
| Serum Amyloid P-Component | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Aged | |
| Albuminuria | |
| Biomarkers | |
| Cross-Sectional Studies | |
| Female | |
| Glomerular Filtration Rate | |
| Humans | |
| Inflammation | |
| Linear Models | |
| Male | |
| Middle Aged | |
| Turkey | |
| Pentraxins |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40620843 | Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational Study. | J Diabetes Res | 2025 | https://conductscience.org/library/papers/40620843 | PubMed |
| 40520240 | Association between skeletal muscle mass to visceral fat area ratio and insulin resistance in type 2 diabetes. | J Diabetes Metab Disord | 2025 | https://conductscience.org/library/papers/40520240 | PubMed |
| 40332236 | Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332236 | PubMed |
| 40299501 | Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299501 | PubMed |
| 36051390 | A meta-analysis of genome-wide gene expression differences identifies promising targets for type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36051390 | PubMed |
| 35708187 | Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease. | Diabetes Metab Res Rev | 2022 | https://conductscience.org/library/papers/35708187 | PubMed |
| 32662255 | Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Preserved Renal Function. | Diabetes Metab J | 2020 | https://conductscience.org/library/papers/32662255 | PubMed |
| 32661627 | Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients. | Int Urol Nephrol | 2020 | https://conductscience.org/library/papers/32661627 | PubMed |
| 32384513 | Monocyte-lymphocyte ratio is a valuable predictor for diabetic nephropathy in patients with type 2 diabetes. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32384513 | PubMed |
| 32133797 | Roles of pattern recognition receptors in diabetic nephropathy. | J Zhejiang Univ Sci B | 2020 | https://conductscience.org/library/papers/32133797 | PubMed |
| 29675428 | PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29675428 | PubMed |
| 29275488 | The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial. | Clin Exp Nephrol | 2018 | https://conductscience.org/library/papers/29275488 | PubMed |
| 28861072 | UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28861072 | PubMed |
| 28119515 | Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy. | Med Sci Monit | 2017 | https://conductscience.org/library/papers/28119515 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APCS | 325 | PubTator's text mining | https://conductscience.org/library/genes/325 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PTX3 | 5806 | PubTator's text mining | https://conductscience.org/library/genes/5806 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27436699
GET https://conductscience.org/api/papers/v1/27436699/authors